BioSpace News Archive

Policy

Teva Makes Move to Block Eli Lilly From Bringing Its Migraine Drug to the U.S.

Teva said Lilly’s planned drug would infringe five patents that cover its own migraine drug, which it sought U.S. Food and Drug Administration approval for on Oct. 16.

October 26, 2017
·
1 min read
Deals

Siemens Summons Three Banks for IPO of Healthineers Unit

Siemens AG is looking to take its Healthineers unit public.

October 26, 2017
·
2 min read
·
Alex Keown
Business

Gilead HCV Woes Continue and Investors are Spooked

Gilead continues to see serious revenue declines in its hepatitis C marketshare, a space it has dominated for several years.

October 26, 2017
·
2 min read
·
Alex Keown
Job Trends

Cambridge-Based Wave Life Sciences Expands Into New Facility Designed to House Up to 200 Employees

Wave Life Sciences has officially opened a new state-of-the art manufacturing facility to support advancement of the company’s stereopure nucleic acid platform.

October 26, 2017
·
2 min read
·
Alex Keown